| Product Code: ETC6210788 | Publication Date: Sep 2024 | Updated Date: Jan 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Austria`s import trend for pregabalin showed a steady increase, driven by rising demand for the medication in the Austrian market. This growth in imports reflects the country`s reliance on external sources to meet domestic demand for pregabalin.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Pregabalin Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Pregabalin Market Revenues & Volume, 2021 & 2031F |
3.3 Austria Pregabalin Market - Industry Life Cycle |
3.4 Austria Pregabalin Market - Porter's Five Forces |
3.5 Austria Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Austria Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Austria Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Austria Pregabalin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Austria |
4.2.2 Growing awareness about the benefits of pregabalin in managing chronic pain |
4.2.3 Rising geriatric population in Austria requiring treatment for neuropathic pain |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products in Austria |
4.3.2 Competition from alternative pain management therapies in the market |
5 Austria Pregabalin Market Trends |
6 Austria Pregabalin Market, By Types |
6.1 Austria Pregabalin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Austria Pregabalin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Austria Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 Austria Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.1.5 Austria Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.1.6 Austria Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Austria Pregabalin Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Austria Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.3 Austria Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 Austria Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Austria Pregabalin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Austria Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Austria Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Austria Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.5 Austria Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
7 Austria Pregabalin Market Import-Export Trade Statistics |
7.1 Austria Pregabalin Market Export to Major Countries |
7.2 Austria Pregabalin Market Imports from Major Countries |
8 Austria Pregabalin Market Key Performance Indicators |
8.1 Number of prescriptions of pregabalin by healthcare providers in Austria |
8.2 Patient adherence rate to pregabalin treatment regimens |
8.3 Number of clinical trials and research studies on pregabalin efficacy and safety in Austria |
9 Austria Pregabalin Market - Opportunity Assessment |
9.1 Austria Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Austria Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Austria Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Austria Pregabalin Market - Competitive Landscape |
10.1 Austria Pregabalin Market Revenue Share, By Companies, 2024 |
10.2 Austria Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here